回盛生物：原料-制剂一体化战略的实施对公司竞争力和盈利能力的提升发挥了重要作用

Core Insights - The implementation of the integrated raw material and formulation strategy has significantly enhanced the company's competitiveness and profitability [2] - The company's active pharmaceutical ingredient (API) business revenue saw substantial growth compared to the same period last year [2] - The company is increasing its investment in microbial fermentation innovation to improve production efficiency and product quality [2] Business Strategy - The company is focusing on expanding its domestic and international market presence to boost capacity utilization [2] - Production plans are being arranged based on market demand, ensuring a responsive approach to changing conditions [2] - The company will disclose sales performance of its API business in its annual and semi-annual reports [2]